RecallDepth
Class II Terminated

RELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per carton, NDC 0049-2340-45; b) 12-count (2 cards x 6 tablets) per carton, NDC 0049-2340-05, Rx only, Made in Ireland, Distributed by Pfizer Roerig, Division of Pfizer Inc., NY, NY 10017.

Company
Pfizer Inc.
Recall Initiated
August 14, 2019
Posted
September 4, 2019
Recall Number
D-1845-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 20,117 cartons; b) 2,502 cartons
Firm Location
New York, NY, United States

Reason for Recall

Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.

Distribution

Nationwide in the USA and Puerto Rico.

Lot / Code Info

Lot #: a) AR5407, Exp 2022 FEB; b) CD4565, Exp 2022 FEB

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls